Cx43 reverses the resistance of A549 lung adenocarcinoma cells to cisplatin by inhibiting EMT

  • Authors:
    • Meiling Yu
    • Cuiling Zhang
    • Li Li
    • Shuying Dong
    • Naiju Zhang
    • Xuhui Tong
  • View Affiliations

  • Published online on: April 29, 2014     https://doi.org/10.3892/or.2014.3163
  • Pages: 2751-2758
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cisplatin (CDDP) is one of the standard first-line chemotherapeutic agents for advanced non-small cell lung cancer (NSCLC). Unfortunately, prolonged exposure to CDDP results in acquired resistance which prevents the successful treatment of lung cancer patients. Thus, it is necessary to explore the mechanism underlying the resistance of NSCLC to CDDP. In the present study, a CDDP-resistant human lung cancer cell line A549/CDDP was established from the parental cell line A549. The results demonstrated that A549/CDDP cells acquired an epithelial-mesenchymal transition (EMT) phenotype, with morphological changes including acquisition of a spindle-like fibroblastic phenotype, downregulation of E-cadherin, upregulation of mesenchymal markers (vimentin, Snail and Slug), and increased capability of invasion and migration. Compared with A549 cells, the A549/CDDP cells showed decreased connexin43 (Cx43) expression. Overexpression of Cx43 reversed EMT and CDDP resistance in the A549/CDDP cells. Conversely, knockdown of Cx43 expression by siRNA-Cx43 initiated EMT and induced CDDP insensitivity in A549 cells. In summary, Cx43 reverses CDDP resistance in A549 CDDP-resistant cells by preventing EMT, making Cx43 a possible therapeutic target for lung cancer.
View Figures
View References

Related Articles

Journal Cover

June-2014
Volume 31 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yu M, Zhang C, Li L, Dong S, Zhang N and Tong X: Cx43 reverses the resistance of A549 lung adenocarcinoma cells to cisplatin by inhibiting EMT. Oncol Rep 31: 2751-2758, 2014
APA
Yu, M., Zhang, C., Li, L., Dong, S., Zhang, N., & Tong, X. (2014). Cx43 reverses the resistance of A549 lung adenocarcinoma cells to cisplatin by inhibiting EMT. Oncology Reports, 31, 2751-2758. https://doi.org/10.3892/or.2014.3163
MLA
Yu, M., Zhang, C., Li, L., Dong, S., Zhang, N., Tong, X."Cx43 reverses the resistance of A549 lung adenocarcinoma cells to cisplatin by inhibiting EMT". Oncology Reports 31.6 (2014): 2751-2758.
Chicago
Yu, M., Zhang, C., Li, L., Dong, S., Zhang, N., Tong, X."Cx43 reverses the resistance of A549 lung adenocarcinoma cells to cisplatin by inhibiting EMT". Oncology Reports 31, no. 6 (2014): 2751-2758. https://doi.org/10.3892/or.2014.3163